UCAN Co
Biotechnology company · Woodbridge, Connecticut, United States
UCAN Co is a biotechnology company headquartered in Woodbridge, Connecticut, United States. Its earliest recorded incorporation is in 2005. It has reported private securities offerings to the US SEC, most recently $5.7 million sold in a notice filed in 2018.
UCAN at a glance
What does UCAN do?
Private fundraising reported to the SEC
6 Form D notices; the most recent reported $5.7 million sold (2018).
Frequently asked questions about UCAN
Where is UCAN headquartered?
UCAN Co is headquartered in Woodbridge, Connecticut, United States.
What does UCAN do?
UCAN Co is a biotechnology company.
When was UCAN founded?
The earliest incorporation on record for UCAN Co is in 2005, according to public company registers.
Similar companies
- Soterix Medical, Inc.Woodbridge, New Jersey, United States
- Mitotherapeutix, LLCWoodbridge, Connecticut, United States
- Myofinity Biosciences IncWoodbridge, Connecticut, United States
- P2 Science, Inc.Woodbridge, Connecticut, United States
- AlloMek Therapeutics, LLCWoodbridge, Connecticut, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences